| Name | Date | Type | Actions |
|---|---|---|---|
2016 calendar of financial communication December 15, 2015 (Lure, France) – Vétoquinol published its calendar of financial communication for 2016. |
Agenda | ||
Monthly information regarding the total number of voting rights and shares making of the share capital - November 2015 As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers » |
Voting rights | ||
Programme de rachat - novembre 2015 (french) Tableau de déclaration mensuelle des opérations réalisées par un émetteur sur ses propres titres |
Monthly communication regarding buyback programs | ||
Vetoquinol et nippon Zenyaku Kogyo Co. ltd. signent un accord de joint-venture au Japon Vetoquinol and Nippon Zenyaku Kogyo Co., Ltd., also operating under the trade name “Zenoaq”, announced today the signature of a joint-venture agreement to develop, register and market a range of animal health products in Japan. |
Public releases | ||
Monthly information regarding the total number of voting rights and shares making of the share capital - Octobre 2015 As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers » |
Voting rights | ||
Programme de rachat - octobre 2015 (french) Tableau de déclaration mensuelle des opérations réalisées par un émetteur sur ses propres titres |
Monthly communication regarding buyback programs | ||
September 2015 year-to-date sales up 8.7% to €251.8 million Vetoquinol sales for the first nine months of 2015 rose 8.7% to €251.8 million, boosted by a positive currency impact of €13.7 million. Organic growth for the same period came to 0.7%. |
Public releases | ||
Monthly information regarding the total number of voting rights and shares making of the share capital - September 2015 As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers » |
Voting rights | ||
Programme de rachat - septembre 2015 (french) Tableau de déclaration mensuelle des opérations réalisées par un émetteur sur ses propres titres |
Monthly communication regarding buyback programs | ||
VETOQUINOL launches UPCARD©, an innovative drug for congestive heart failure in dogs Vétoquinol continues the deployment of its reference products with the European launch of UPCARD©, an innovative drug designed to treat congestive heart failure in dogs. |
Public releases |